友情提示:以下期刊信息可能会有更新,仅供参考,请在投稿前自行登录期刊官网仔细核实。
期刊名
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
N-S ARCH PHARMACOL
ISSN / eISSN
0028-1298 / 1432-1912
目标和范围
Naunyn-Schmiedeberg's Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg's Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.
研究方向
药学
CiteScore
6.20
查看趋势图
CiteScore 学科排名
类别 | 分区 | 排名 |
---|---|---|
Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q2 | #107/301 |
Web of Science 核心合集
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
类别 (Journal Citation Reports 2023) | 分区 |
---|---|
PHARMACOLOGY & PHARMACY - SCIE | Q2 |
H-index
83
出版国家或地区
GERMANY
出版商
Springer Berlin Heidelberg
出版周期
Monthly
出版年份
1873
年文章数
174
Open Access
NO
通讯方式
SPRINGER, 233 SPRING ST, NEW YORK , USA, NY, 10013
认证评论
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started